Renaissance Technologies (RenTech)'s SNSE Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 32,041 shares of Sensei Biotherapeutics, Inc. (SNSE) worth $1.01 M, representing 0.00% of the portfolio. First purchased in 2022-Q1, this medium-term investment has been held for 17 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in SNSE, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 20,525 shares. Largest reduction occurred in Q2 2025, reducing 8,865 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Sensei Biotherapeutics (SNSE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Sensei Biotherapeutics (SNSE) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +20,525 | Add 178.23% | 32,041 | $31.52 |
| Q4 2025 | +1,100 | Add 10.56% | 11,516 | $10.67 |
| Q3 2025 | +10,416 | New Buy | 10,416 | $9.45 |
| Q2 2025 | -8,865 | Sold Out | 0 | $0.00 |
| Q1 2025 | +1,025 | Add 13.07% | 8,865 | $7.88 |
| Q4 2024 | -2,939 | Reduce 27.27% | 7,840 | $9.80 |
| Q3 2024 | -410 | Reduce 3.66% | 10,779 | $11.96 |
| Q2 2024 | +639 | Add 6.06% | 11,189 | $12.40 |
| Q1 2024 | +3,375 | Add 47.04% | 10,550 | $21.04 |
| Q4 2023 | +2,985 | Add 71.24% | 7,175 | $13.80 |
| Q3 2023 | -285 | Reduce 6.37% | 4,190 | $15.99 |
| Q2 2023 | -1,785 | Reduce 28.51% | 4,475 | $0.02 |
| Q1 2023 | -2,368 | Reduce 27.45% | 6,260 | $0.03 |
| Q4 2022 | -1,662 | Reduce 16.15% | 8,628 | $0.03 |
| Q3 2022 | -2,060 | Reduce 16.68% | 10,290 | $31.00 |
| Q2 2022 | +8,190 | Add 196.88% | 12,350 | $45.43 |
| Q1 2022 | +4,160 | New Buy | 4,160 | $46.15 |
Renaissance Technologies (RenTech)'s Sensei Biotherapeutics Investment FAQs
Renaissance Technologies (RenTech) first purchased Sensei Biotherapeutics, Inc. (SNSE) in Q1 2022, acquiring 4,160 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Sensei Biotherapeutics, Inc. (SNSE) for 17 quarters since Q1 2022.
Renaissance Technologies (RenTech)'s largest addition to Sensei Biotherapeutics, Inc. (SNSE) was in Q1 2026, adding 32,041 shares worth $1.01 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 32,041 shares of Sensei Biotherapeutics, Inc. (SNSE), valued at approximately $1.01 M.
As of the Q1 2026 filing, Sensei Biotherapeutics, Inc. (SNSE) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Sensei Biotherapeutics, Inc. (SNSE) was 32,041 shares, as reported at the end of Q1 2026.